Doctor’s Passport

Find your next topic

Explore the current textbook

CardiologyRespiratoryNeurology
Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Textbook/Neurosurgery/Acute hydrocephalus after haemorrhage or tumour
Full textbook

Acute hydrocephalus after haemorrhage or tumour

Detect neurological deterioration caused by acute hydrocephalus after spontaneous haemorrhage or an intracranial tumour, separate their mechanisms, and coordinate urgent CSF diversion with definitive cause control.

26 min full readUK scopeSources checked 13 Sept 2026Clinical review pending
Saved on this device
!
Acute hydrocephalus is a time-critical cause of decline

New drowsiness, reduced GCS, repeated vomiting, pupil or gaze change, weakness, posturing or abnormal breathing after intracranial haemorrhage or with a tumour may represent ventricular obstruction and raised pressure.

Action: Activate emergency anaesthetic and neurosurgical review, stabilise physiology, repeat a structured neurological examination, obtain immediate CT when safe, and prepare cause-appropriate CSF diversion or surgery without delaying for routine ward investigations.

Open the sections you need. The overview is shown first.
01Core principlesThe concepts and mechanisms needed to understand the subject.

Blood causes acute hydrocephalus by entering and blocking narrow CSF pathways or by filling the subarachnoid space and disrupting absorption. Aneurysmal SAH may obstruct the ventricular outlets acutely and later produce communicating hydrocephalus. Spontaneous intracerebral haemorrhage can rupture into the ventricles; intraventricular clot increases pressure burden and may obstruct the aqueduct or fourth-ventricular outlets. These are non-traumatic haemorrhage pathways. Traumatic acute subdural, extradural and contusional bleeding require a separate head-injury pathway and should not inherit aneurysmal-SAH or spontaneous-ICH recommendations.

Tumour-related hydrocephalus is anatomical. A colloid cyst near a foramen of Monro can cause intermittent or abrupt obstruction; a pineal, tectal or midbrain lesion can narrow the aqueduct; a fourth-ventricular or cerebellar mass can obstruct the fourth ventricle or its outlets. Tumour oedema and mass effect may add a compartmental pressure gradient. In an unstable patient, CT defines the immediate pressure problem rapidly. Once stabilised, contrast MRI and the tumour pathway define the lesion and definitive plan.

Temporary diversion, often with an EVD, can rapidly lower ventricular pressure, provide CSF drainage and allow ventricular pressure monitoring. It also creates risks of tract haemorrhage, malposition, infection, blockage, overdrainage and accidental disconnection. In some obstructive tumours, endoscopic third ventriculostomy or definitive tumour surgery may avoid or supersede prolonged external drainage; in haemorrhage, permanent shunting may be needed if absorption does not recover. The choice belongs to the responsible neurosurgical team and depends on anatomy, aetiology, age, bleeding risk and anticipated course.

The examination drives urgency. NICE recommends diagnosing hydrocephalus after aneurysmal SAH from symptoms and signs plus comparison of current and previous imaging, and considering CSF drainage or diversion when neurological deterioration is caused by acute hydrocephalus. European spontaneous-ICH guidance recommends EVD when intraventricular extension and hydrocephalus contribute to impaired consciousness. Neither statement authorises routine drainage of incidental ventriculomegaly or dictates one device setting.

Key points

  • After aneurysmal SAH, hydrocephalus can be acute from ventricular/outlet obstruction by blood or later from impaired absorption; diagnose from symptoms and change on imaging.
  • In spontaneous ICH with intraventricular extension, hydrocephalus contributing to impaired consciousness is an accepted indication for EVD to reduce mortality, although functional-outcome evidence is less certain.
  • Posterior-fossa haemorrhage is not simply supratentorial ICH in a different location: direct brainstem compression and a tight compartment can make evacuation or decompression central to rescue.
  • Tumours obstruct by site: colloid or other third-ventricular lesions can block Monro; tectal or pineal lesions can block the aqueduct; cerebellar and fourth-ventricular masses can obstruct the fourth ventricle or outlets.
  • CSF diversion treats the pressure consequence, not the source. A ruptured aneurysm still needs rebleeding prevention, spontaneous ICH needs its own acute pathway, and a tumour needs specialist imaging, tissue and MDT planning.
  • Do not prescribe a universal EVD height, volume limit, clamping schedule or troubleshooting manoeuvre. Use the named neurosurgical unit and device protocol.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Post-SAH deteriorationRed flag

Reassess headache, vomiting, GCS components, pupils and focal signs. Compare CT for new ventricular enlargement, intraventricular blood and cisternal obstruction while also considering rebleeding, seizure, ischaemia, sodium disturbance and infection.

ICH with ventricular extensionRed flag

Reduced consciousness with IVH and hydrocephalus supports urgent EVD assessment. Keep spontaneous ICH distinct from traumatic bleeding, and remember that EVD treats hydrocephalus rather than the parenchymal haematoma itself.

Posterior-fossa haemorrhageRed flag

Look for declining consciousness, gaze abnormality, ataxia when testable, cranial-nerve signs and brainstem compression on CT. Adult spontaneous cerebellar ICH with hydrocephalus or brainstem compression requires urgent direct neurosurgical assessment rather than assuming an EVD alone completes treatment.

Tumour obstruction

Progressive headache, vomiting, diplopia, upgaze difficulty, gait change or drowsiness with a third-ventricular, aqueductal or posterior-fossa mass can indicate acute obstructive hydrocephalus; when imaging confirms it, ENLS supports emergent neurosurgical EVD management while tumour characterisation proceeds.

Drain failure after rescueRed flag

New deterioration, unexpectedly absent drainage, loss of an expected CSF waveform, fluid leakage, tubing disruption or a changed drain position requires immediate escalation without unsupervised flushing or re-levelling.

Competing causes

Hypoxaemia, hypotension, sedatives, seizures, metabolic disturbance, infection, rebleeding and tumour oedema can coexist. Do not attribute all reduced consciousness to hydrocephalus without checking physiology and imaging.

Red flags requiring action

  • Any fall in GCS or new pupil, gaze, motor or respiratory abnormality after subarachnoid, intraventricular or intracerebral haemorrhage.
  • Rapid vomiting, headache, reduced alertness or new sixth-nerve or upgaze abnormality in a patient with a third-ventricular or posterior-fossa tumour.
  • Intraventricular extension with enlarging ventricles and impaired consciousness supports urgent EVD assessment in spontaneous ICH.
  • Cerebellar haemorrhage or posterior-fossa tumour with hydrocephalus and brainstem compression may need lesion evacuation or decompression; ventricular drainage alone may be insufficient or hazardous.
  • A blocked or dislodged CSF drain, sudden cessation or excess of drainage, new wound leak or acute neurological change is an immediate device-and-patient emergency.
  • Anticoagulant use changes haemorrhage management, but reversal agent, dose and availability must follow the current haemorrhage-specific UK and local pathway.
03Interpreting evidenceInformation, measurements and their limitations.
Reasoning sequence

Consider the information, its meaning and its limitations before deciding what follows.

  1. 01
    Immediate non-contrast CT head
    Why
    Identify acute hydrocephalus, intraventricular blood, haematoma expansion, posterior-fossa compression and gross tumour mass effect.
    Interpretation and limitations
    Compare with the prior scan and correlate ventricular change with neurological trajectory. Basal-cistern effacement, transependymal oedema and a visible obstruction increase concern, but absence of dramatic enlargement does not dismiss a deteriorating examination.
  2. 02
    CT angiography or haemorrhage-specific vascular imaging
    Why
    Identify a ruptured aneurysm or other macrovascular cause when the bleed pattern and pathway indicate it.
    Interpretation and limitations
    Vascular imaging and aneurysm treatment proceed within the aSAH or spontaneous-ICH pathway. CSF drainage does not secure an aneurysm or complete cause investigation.
  3. 03
    Contrast MRI brain when stable
    Why
    Define tumour location, aqueductal and fourth-ventricular relationships, dissemination and tissue characteristics for specialist planning.
    Interpretation and limitations
    For people over 16 with suspected glioma, NICE recommends standard structural MRI and specialist MDT referral at first radiological diagnosis. MRI must not delay emergency decompression in an unstable patient.
  4. 04
    Serial neurological and physiological monitoring
    Why
    Detect pressure recurrence, rebleeding, posterior-fossa deterioration or drain failure.
    Interpretation and limitations
    Record GCS components, pupils, limb response, respiratory pattern, blood pressure and oxygenation. Escalate any confirmed decline and repeat imaging or device assessment under the unit pathway.
  5. 05
    Coagulation and medicine history
    Why
    Identify antithrombotic exposure or coagulopathy relevant to ongoing bleeding and drain insertion.
    Interpretation and limitations
    Record exact drug, dose, last administration, renal function and laboratory context. Apply the current bleed-specific UK/local reversal pathway; licensing, commissioning and local availability are not interchangeable.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked case: IVH deteriorationSpontaneous ICH with enlarging ventriclesAn adult with spontaneous ICH and intraventricular extension becomes drowsier and CT shows acute hydrocephalus.
  1. 1Recognise hydrocephalus contributing to impaired consciousness, call neurosurgery and critical care immediately, and stabilise airway, oxygenation and circulation.
  2. 2Repeat and document GCS components, pupils and motor findings, obtain urgent comparison CT, and assess the haemorrhage-specific blood-pressure, haemostasis and cause pathway in parallel.
  3. 3Prepare for EVD insertion by the neurosurgical team because current spontaneous-ICH guidance recommends ventricular drainage in this clinical pattern to reduce mortality.
  4. 4Do not treat the EVD as definitive control of the parenchymal bleed; continue spontaneous-ICH monitoring and assess whether evacuation or other surgery is indicated by location, mass effect and trajectory.
  5. 5After insertion, use the named unit/device protocol for level, drainage, clamping, sampling and troubleshooting, and verify response through examination, imaging and authorised device observations.
02Posterior-fossa pathwayHydrocephalus plus local brainstem compressionA cerebellar haemorrhage or posterior-fossa tumour causes ventricular enlargement and neurological decline.
  1. 1Escalate immediately to a neurosurgeon capable of posterior-fossa intervention and provide simultaneous airway and physiological stabilisation.
  2. 2Review CT for haematoma or tumour size, fourth-ventricular compression, cistern effacement and brainstem compression rather than focusing on ventricular size alone.
  3. 3Coordinate CSF diversion with lesion evacuation or decompression when required; do not assume ventricular drainage alone resolves the confined posterior-fossa mass.
  4. 4Repeat examination and imaging promptly because upward or downward tissue shift, rebleeding, oedema and drain complications can evolve after initial treatment.
03Tumour pathwayObstructing tumour without immediate collapseA stable patient has ventriculomegaly caused by a third-ventricular, aqueductal or posterior-fossa lesion.
  1. 1Obtain contrast MRI with appropriate structural sequences and refer to the specialist neurosurgical and tumour MDT pathway, using NICE NG99 only for people over 16.
  2. 2Define whether immediate CSF diversion, endoscopic bypass, tumour resection, biopsy or staged treatment best controls both the obstruction and the lesion.
  3. 3Establish a documented deterioration plan while awaiting intervention, including observations and the findings that trigger emergency imaging and escalation.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
  • Perform frequent unit-specified GCS component, pupil, motor, respiratory and cardiovascular observations; a new trajectory matters more than one score.
  • Compare serial CT for ventricular size, intraventricular clot, haematoma expansion, posterior-fossa compression, transependymal oedema and catheter position when present.
  • Monitor an EVD only through the authorised protocol, including prescribed reference level, drainage strategy, clamp status and escalation limits.
  • Track bleeding risk using the exact antithrombotic, last dose, renal function and current haemorrhage-specific reversal plan rather than a generic reversal rule.
  • After tumour stabilisation, transfer follow-up to the age-appropriate specialist MDT; new or changing neurological signs require clinical review and appropriate imaging.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Diversion is consequence control

An EVD can relieve hydrocephalus but cannot secure a ruptured aneurysm, remove a parenchymal haematoma or establish tumour histology.

Posterior fossa is different

A relatively small lesion can compress the fourth ventricle and brainstem. Ventricular drainage must be integrated with direct lesion and compartment management.

Compare, do not just measure

NICE anchors hydrocephalus diagnosis after aSAH in symptoms and signs plus current-versus-previous imaging, avoiding a universal ventricular-width threshold.

Haemorrhages stay separate

Aneurysmal SAH, spontaneous ICH with IVH and traumatic cranial bleeds differ in cause control, evidence and follow-up even when each can produce acute hydrocephalus.

Protocol is part of the device

Drain behaviour changes with patient position and reference level. Safe management requires the current named local/device protocol and trained staff.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Attributing post-SAH drowsiness automatically to hydrocephalus without considering rebleeding, seizure, ischaemia, infection or metabolic disturbance.

  2. 02

    Assuming EVD alone is adequate for cerebellar haemorrhage or a posterior-fossa tumour that is directly compressing the brainstem.

  3. 03

    Delaying emergency CT and neurosurgical assessment for contrast MRI in an unstable tumour patient.

  4. 04

    Applying spontaneous-ICH or aneurysmal-SAH recommendations to traumatic subdural, extradural or contusional haemorrhage.

  5. 05

    Treating CSF diversion as definitive control of the aneurysm, haematoma or tumour.

  6. 06

    Using a remembered EVD setting or anticoagulant-reversal recipe without the current responsible service protocol.

Practice

Two practice questions

Question 1 of 20 correct
NeurosurgeryOriginal SBA

Deterioration with intraventricular extension

An adult with spontaneous intracerebral haemorrhage and intraventricular extension becomes progressively drowsy. Repeat CT shows enlarging ventricles. What is the most appropriate next step?

Sources and review status5 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 13 Sept 2026; clinical approval remains outstanding.

  • NICE NG228 aneurysmal SAH recommendationsPublished 23 November 2022; recommendations 1.3.3 to 1.3.5 and hydrocephalus rationale read 13 September 2026. UK guidance specific to aneurysmal SAH.
  • ESO EANS spontaneous ICH guidelinePublished 2025; neurosurgical-treatment and intraventricular-haemorrhage sections read 13 September 2026 for adults with spontaneous ICH, IVH, hydrocephalus and posterior-fossa disease. Not a traumatic-bleed guideline.
  • NCS external ventricular drain consensusPublished 2016; adult indications, complications, weaning and management-bundle sections read 13 September 2026. Supports temporary diversion and device-risk boundaries, not universal settings.
  • ENLS intracranial hypertension protocolVersion 6.0, September 2024; diagnosis and Tier One CSF-drainage sections read 13 September 2026. Supports emergent EVD management for imaging-confirmed acute obstructive hydrocephalus; it is not a tumour-treatment or UK device-setting protocol.
  • NICE NG99 brain tumour recommendationsPublished 2018, updated 2021; recommendations 1.1.1 to 1.1.2 and symptom-triggered review sections read 13 September 2026. Applies to primary tumours and metastases in people over 16; not an acute-hydrocephalus procedure protocol.
Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom